Evidence map›Paper›PMID 35566023›Full record

ArticleMolecules (Basel, Switzerland)2022

Xin Ji, Zhensheng Wang, Qianqian Chen, Jingzhong Li, Heng Wang, Zenglei Wang, Lan Yang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. To quest new targets ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Review
  4. Proposition ofCombinatorial chemistry & high throughput screening · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xin JiInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Zhensheng WangDepartment of Microbiology and Parasitology, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, China.
Qianqian ChenNHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100006, China.
Jingzhong LiNHC Key Laboratory of Echinococcosis Prevention and Control, 21# Linkuo North Road, Chengguan District, Lhasa 850000, China.
Heng WangDepartment of Microbiology and Parasitology, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, China.
Zenglei WangNHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100006, China.ORCID 0000-0003-4229-8426
Lan YangInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNChinese Center For Disease Control and Prevention · CN

Funding

Major National Science and Technology Program of China for Innovative Drug 2017ZX09101002-001-001
6 · The paper itself

Abstract

Malaria chemotherapy is greatly threatened by the recent emergence and spread of resistance in the

Indexed as

AntimalarialsFolic Acid AntagonistsAspartic Acid EndopeptidasesMolecular Docking SimulationPlasmodium falciparumProtozoan ProteinsAntimalarialsAspartic Acid EndopeptidasesFolic Acid AntagonistsplasmepsinProtozoan Proteinsantimalarialsmolecular dockingplasmepsin VPlasmodium falciparumvirtual screening

Identifiers

PMID35566023
PMCPMC9102085
OpenAlexW4224313307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.